Harrington J, Udell JA, Jones WS, Anker SD, et al. Empagliflozin in Patients Post Myocardial Infarction Rationale and Design of the EMPACT-MI Trial. Am Heart J 2022 May 17. pii: S0002-8703(22)00095.
PMID: 35595091